Arlington Trust’s Medpace MEDP Stock Holding History

Arlington Trust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$628	–	650
2025 Q2	$628	Buy	+2	New	+$600	﹤0.01%	625

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arlington Trust's MEDP Position: Q3 2025 in Review

Arlington Trust sold out of Medpace (MEDP) in Q3 2025, closing a stake of 2 shares — an estimated $628 sold.

Arlington Trust first reported a position in MEDP in Q2 2025 and held it in 1 quarter. The position peaked at $628 in Q2 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

Arlington Trust reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
Arlington Trust sold 2 Medpace shares in Q3 2025, an estimated $628.
Arlington Trust first reported a position in Medpace in Q2 2025 and held it in 1 quarter.
Arlington Trust's Medpace position peaked at $628 in Q2 2025.
672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Arlington Trust's 13F filing for Q3 2025, filed 28 Oct 2025.